IMMUNOSUPPRESSANT FORMULATIONS

The present invention relates to a solid phase pharmaceutical composition comprising one or more pharmaceutically acceptable excipients and an active pharmaceutical ingredient ("API") which is a compound of formula A1 or A2 or a pharmacologically acceptable salt, solvate or hydrate thereof...

Full description

Saved in:
Bibliographic Details
Main Authors PHILIPPE BOUILLOT, EMERIC REYNAUD
Format Patent
LanguageEnglish
Portuguese
Published 25.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a solid phase pharmaceutical composition comprising one or more pharmaceutically acceptable excipients and an active pharmaceutical ingredient ("API") which is a compound of formula A1 or A2 or a pharmacologically acceptable salt, solvate or hydrate thereof, wherein the API is not exposed to a basic compound.
Bibliography:Application Number: PT20120700262T